R-CHOP without Radiation in Frontline Management of Primary Mediastinal B-cell Lymphoma

Prior to the introduction of rituximab, primary mediastinal B-cell lymphoma (PMBCL) had high rates of treatment failure with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP), prompting the use of consolidative mediastinal radiation or more intensive chemotherapy regimens. Cure rates...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Leuk Lymphoma
Glavni autori: Messmer, Marcus, Tsai, Hua-Ling, Varadhan, Ravi, Swinnen, Lode J., Jones, Richard J., Ambinder, Richard F., Shanbhag, Satish P., Borowitz, Michael J., Wagner-Johnston, Nina
Format: Artigo
Jezik:Inglês
Izdano: 2019
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6472975/
https://ncbi.nlm.nih.gov/pubmed/30656983
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10428194.2018.1519812
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items